Skip to main content
SpringerLink
Log in

Clinical relevance of cathepsin B-like enzyme activity and cysteine proteinase inhibitor in melanocytic tumours

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

We studied the relationship between cathepsin B (CB)-like enzyme activities and cysteine proteinase inhibitor (CPI) activities in lesions of human pigmented naevi (PN), primary melanomas (PM) and metastases/metastatic melanomas (MM). The CB-like enzyme activities in PM and MM were 2.5 and 6.8 times higher than in PN, respectively. The CB-like/CPI ratios in PM and MM were 1.9 and 11.6 times higher than in PN, respectively. CPI had the highest activity in PM and the lowest activity in MM. The disease-free interval of patients with a high CB-like enzyme activity (≧80 U/mg protein) and/or a high CB-like/CPI ratio (≧7) was shorter than that of patients with a low CB-like enzyme activity (<80 U/mg protein) and/or a low CB-like/CPI ratio (<7). Analysis of CB-like enzyme activity and/or the CB-like/CPI ratio may be useful in predicting the prognosis of human malignant melanoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baici A, Knöpfel M (1986) Cysteine proteinases produced by cultured rabbit v2 carcinoma cells and rabbit skin fibroblasts. Int J Cancer 38: 753–761

    PubMed  Google Scholar 

  2. Clark WH Jr, From L, Bernardino EA, Mihm MC (1969) The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29: 705–727

    PubMed  Google Scholar 

  3. Davies ME, Barrett AJ (1984) Immunolocalization of human cystatins in neutrophils and lymphocytes. Histochemistry 80: 373–377

    PubMed  Google Scholar 

  4. FrÄki JE, Nieminen S, Hopsu-Have VK (1979) Proteolytic enzymes and plasminogen activator in melanoma. J Cutan Pathol 6: 195–200

    PubMed  Google Scholar 

  5. Harvima RJ, Yabe K, FrÄki JE, Fukuyama K, Epstein WL (1987) Separation and identification of cathepsins in newborn rat epidermis. J Invest Dermatol 88: 393–397

    PubMed  Google Scholar 

  6. Hopsu-Havu VK, Joronen I, Rinne A, JÄrvinen M (1985) Production of acid and neutral cysteine-proteinase inhibitors by a cultured human skin epithelium cell line. Arch Dermatol Res 277: 452–456

    PubMed  Google Scholar 

  7. JÄrvinen M, Hopsu-Havu VK (1975) α-N-benzoylarginine-2-naphthylamide hydrolase (cathepsin B1 ?) from rat skin. I. Preliminary experiments with skin extract. Acta Chem Scand [B] 29: 671–676

    Google Scholar 

  8. JÄrvinen M, Hopsu-Havu VK (1975) α-N-benzoylarginine-2-naphthylamide hydrolase (cathepsin B1 ?) from rat skin. II. Purification of the enzyme and demonstration of two inhibitors in the skin. Acta Chem Scand [B] 29: 772–780

    Google Scholar 

  9. Katunuma N, Kominami E (1989) Lysosomal thiol proteinases and their endogenous inhibitors in rat skin. In: Ogawa H, Lazarus GS, Hopsu-Havu VK (eds) The biological role of proteinases and their inhibitors in skin. University of Tokyo Press, Tokyo, pp 3–11

    Google Scholar 

  10. Liotta LA, Rao CN, Wewer UM (1986) Biochemical interactions of tumor cells with the basement membrane. Ann Rev Biochem 55: 1037–1057

    PubMed  Google Scholar 

  11. Mullins DE, Rohrlich ST (1983) The role of proteinases in cellular invasiveness. Biochim Biophys Acta 695: 177–214

    PubMed  Google Scholar 

  12. Nishida Y, Tsushima H, Toki N, Sumi H, Mihara H (1986) Thiol protease inhibitor released from human malignant melanoma. In: Turk V (ed) Cysteine proteinases and their inhibitors. Walter de Gruyter, Berlin New York, pp 751–760

    Google Scholar 

  13. Poole AR, Tiltman KJ, Recklies AD, Stoker TAM (1978) Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature 273: 545–547

    PubMed  Google Scholar 

  14. Redinbaugh MG, Campbell WH (1985) Adaptation of the dyebinding protein assay to microtiter plates. Anal Biochem 147: 144–147

    PubMed  Google Scholar 

  15. Rozhin J, Gomez AP, Ziegler GH, Nelson KK, Chang YS, Fong D, Onoda JM, Honn KV, Sloane BF (1990) Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors. Cancer Res 50: 6278–6284

    PubMed  Google Scholar 

  16. Sheahan K, Shuja S, Murnane MJ (1989) Cysteine protease activities and tumour development in human colorectal carcinoma. Cancer Res 49: 3809–3814

    PubMed  Google Scholar 

  17. Sloane BF (1990) Cathepsin B and cystatins: evidence for a role in cancer progression. Semin Cancer Biol 1: 137–152

    PubMed  Google Scholar 

  18. Sloane BF, Honn KV, Sadler JG, Turner WA, Kimpson JJ, Taylor JD (1982) Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. Cancer Res 42: 980–986

    PubMed  Google Scholar 

  19. Sloane BF, Moin K, Krepela E, Rozhin J (1990) Cathepsin B and its endogenous inhibitors: the role in tumor malignancy. Cancer Metastasis Rev 9: 333–352

    PubMed  Google Scholar 

  20. Tsushima H, Sumi H, Mihara H, Joronen I, Hopsu-Havu VK (1988) Cysteine proteinase inhibitors in human melanoma transplanted into nude mice. Biol Chem Hoppe Seyler 369: 243–250

    PubMed  Google Scholar 

  21. Union Internationale Contre le Cancer (1987) TNM classification of malignant tumours, 4th edn. Springer, Berlin, pp 83–91

    Google Scholar 

  22. Weiss RE, Liu BCS, Athlering T, Dubeau L, Droller MJ (1990) Mechanisms of human bladder tumor invasion: role of protease cathepsin B. J Urol 144: 798–804

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Kumamoto University School of Medicine, 1-1-1 Honjo, 860, Kumamoto, Japan

    A. Yoshii, T. Kageshita & T. Ono

  2. Department of Hygiene, Kawasaki Medical School, Kawasaki, Japan

    H. Tsushima

Authors
  1. A. Yoshii
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Kageshita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Tsushima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Ono
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshii, A., Kageshita, T., Tsushima, H. et al. Clinical relevance of cathepsin B-like enzyme activity and cysteine proteinase inhibitor in melanocytic tumours. Arch Dermatol Res 287, 209–213 (1995). https://doi.org/10.1007/BF01262334

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01262334

Key words

Search

Navigation